Acadia Healthcare (ACHC) Fundamental Analysis: Revenue, Earnings & Valuation

7.92 / 10

Outperform

Fundamental analysis rates ACHC as Outperform with a 7.9/10 score. Revenue‑to‑market‑value and cash‑to‑market‑value ratios are strong, boosting outlook. Conversely, inventory turnover is modest and year‑over‑year EPS growth is sharply negative, tempering the bullish case.

Analysis Checks(5/10)

Revenue-MV

Value1.52

Score2/3

Weight32.03%

1M Return3.89%

Net cash flow from operating activities per share (YoY growth rate %)

Value3.19

Score3/3

Weight39.38%

1M Return5.07%

Inventory turnover ratio

Value106.57

Score1/3

Weight11.82%

1M Return1.74%

Net income-Revenue

Value-0.04

Score0/3

Weight-14.25%

1M Return-2.25%

Basic earnings per share (YoY growth rate %)

Value-535.84

Score0/3

Weight-4.96%

1M Return-0.88%

Total profit (YoY growth rate %)

Value-411.79

Score0/3

Weight-13.98%

1M Return-2.61%

Net cash flow from operating activities (YoY growth rate %)

Value1.70

Score2/3

Weight27.72%

1M Return3.84%

Cash-UP

Value-0.16

Score2/3

Weight8.00%

1M Return0.89%

Diluted earnings per share (YoY growth rate %)

Value-537.41

Score0/3

Weight-5.18%

1M Return-0.92%

Cash-MV

Value0.03

Score2/3

Weight19.41%

1M Return2.77%

Is ACHC undervalued or overvalued?

ACHC scores 7.92/10 on fundamentals and holds a Discounted valuation at present. Backed by its -41.37% ROE, -32.96% net margin, -1.91 P/E ratio, 0.99 P/B ratio, and -535.84% earnings growth, these metrics solidify its Outperform investment rating.